For example, alterations in RPs such as RPL5 (uL5), RPL10 (uL16), RPS15 (uS19), RPL11 (uL15), and RPL22 (eL22) have been described in 10–40% of multiple tumor types. The gene discussed is RPL10; the disease is neoplasm.